Immune phenotypic analysis of tumor-infiltrating T cells revealed that co-administration of CXB to the combination of CTX and ICB boosted the activation of CD8+ and CD4+ T cells, which displayed significantly higher production of IFNγ and surface expression of the activation marker CD44 (Fig. 6i, j). The gene discussed is CD4; the disease is neoplasm.